Privia Health Group, Inc.(PRVA)Earnings, Financials & Key Ratios

PRVA•NASDAQ

$23.99

$3.01B mkt cap·133.3× P/E·Price updated May 6, 2026

SectorHealthcare IndustryHealthcare IT Sub-IndustryCare Delivery Networks and Value-Based Care

AboutPrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.Show more

Revenue$2.12B+22.3%
EBITDA$44M+82.0%
Net Income$23M+59.3%
EPS (Diluted)0.18+63.6%
Gross Margin9.87%-3.1%
EBITDA Margin2.08%+48.9%
Operating Margin1.61%+64.9%
Net Margin1.08%+30.3%
ROE3.11%+39.5%
ROIC9.9%+64.8%
Debt/Equity0.01+47.3%

Technical→

PRVA Key Insights

Privia Health Group, Inc. (PRVA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 21.0%
✓Efficient asset utilization: 1.6x turnover

✗Weaknesses

✗Weak 3Y average ROE of 3.1%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

PRVA Price & Volume

Privia Health Group, Inc. (PRVA) stock price & volume — 10-year historical chart

Loading chart...

PRVA Growth Metrics

Privia Health Group, Inc. (PRVA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years21.04%

3 Years16.1%

TTM22.26%

Profit CAGR

10 Years-

5 Years-6.01%

3 Years-

TTM59.33%

EPS CAGR

10 Years-

5 Years-9.71%

3 Years-

TTM51.92%

Return on Capital

10 Years-3.74%

5 Years-11.41%

3 Years3.61%

Last Year4.6%

PRVA Recent Earnings

Privia Health Group, Inc. (PRVA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 2/12 qtrs (17%)●Beat Revenue 5/12 qtrs (42%)

Q1 2026Latest

Feb 26, 2026

EPS

$0.07

Est $0.04

+75.0%

Revenue

$541M

Est $516M

+4.8%

Q4 2025

Nov 6, 2025

EPS

$0.05

Est $0.06

-16.7%

Revenue

$580M

Est $517M

+12.4%

Q3 2025

Aug 7, 2025

EPS

$0.02

Est $0.05

-60.0%

Revenue

$521M

Est $486M

+7.3%

Q2 2025

May 8, 2025

EPS

$0.03

Est $0.06

-50.0%

Revenue

$480M

Est $459M

+4.7%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 26, 2026	$0.07vs $0.04+75.0%	$541Mvs $516M+4.8%
Q4 2025	Nov 6, 2025	$0.05vs $0.06-16.7%	$580Mvs $517M+12.4%
Q3 2025	Aug 7, 2025	$0.02vs $0.05-60.0%	$521Mvs $486M+7.3%
Q2 2025	May 8, 2025	$0.03vs $0.06-50.0%	$480Mvs $459M+4.7%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
AGIOAgios Pharmaceuticals, Inc.Direct Competitor	1.6B	26.98	-3.79	48.03%	-6.4%	-34.11%	0.05
CNCCentene CorporationDirect Competitor	27.31B	55.32	-4.06	19.44%	-3.25%	-28.6%	0.94
ALHCAlignment Healthcare, Inc.Direct Competitor	3.71B	18.14	-4902.70	46.06%	0.47%	11.5%	1.89
OSCROscar Health, Inc.Product Competitor	5.14B	19.84	-11.74	27.5%	-0.3%	-3.26%	0.44
DOCSDoximity, Inc.Product Competitor	5.17B	25.69	23.14	19.98%	37.54%	24.45%	0.01
WELLWelltower Inc.Product Competitor	151.66B	216.47	155.73	35.82%	12.31%	3.49%	0.49
UNHUnitedHealth Group IncorporatedSupply Chain	333.37B	367.28	27.76	11.81%	2.68%	11.54%	0.77
CVSCVS Health CorporationSupply Chain	111.32B	86.86	62.49	7.85%	0.72%	3.86%	1.24

Compare PRVA vs Peers

Privia Health Group, Inc. (PRVA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AGIO

Most directly comparable listed peer for PRVA.

Scale Benchmark

vs UNH

Larger-name benchmark to compare PRVA against a more recognizable public peer.

Peer Set

Compare Top 5

vs AGIO, CNC, ALHC, OSCR

PRVA Income Statement

Privia Health Group, Inc. (PRVA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	657.61M	786.36M	817.08M	966.22M	1.36B	1.66B	1.74B	2.12B
Revenue Growth %	-	19.58%	3.91%	18.25%	40.41%	22.19%	4.74%	22.26%
Cost of Goods Sold	601.15M	717.89M	734.49M	902.56M	1.22B	1.5B	1.56B	1.91B
COGS % of Revenue	91.41%	91.29%	89.89%	93.41%	90.07%	90.26%	89.81%	90.13%
Gross Profit	56.46M▲ 0%	68.47M▲ 21.3%	82.58M▲ 20.6%	63.66M▼ 22.9%	134.78M▲ 111.7%	161.5M▲ 19.8%	176.85M▲ 9.5%	209.43M▲ 18.4%
Gross Margin %	8.59%	8.71%	10.11%	6.59%	9.93%	9.74%	10.19%	9.87%
Gross Profit Growth %	-	21.28%	20.61%	-22.91%	111.72%	19.82%	9.51%	18.42%
Operating Expenses	54.3M	52.41M	57.2M	281.1M	153.9M	140.85M	159.87M	175.19M
OpEx % of Revenue	8.26%	6.66%	7%	29.09%	11.34%	8.5%	9.21%	8.25%
Selling, General & Admin	53.23M	50.98M	55.36M	278.63M	149.33M	134.32M	152.6M	165.29M
SG&A % of Revenue	8.1%	6.48%	6.78%	28.84%	11.01%	8.1%	8.79%	7.79%
Research & Development	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-
Other Operating Expenses	1.07M	1.43M	1.84M	2.46M	4.57M	6.53M	7.27M	9.91M
Operating Income	2.15M▲ 0%	16.06M▲ 645.3%	25.38M▲ 58.0%	-217.44M▼ 956.7%	-19.12M▲ 91.2%	20.65M▲ 208.0%	16.98M▼ 17.8%	34.23M▲ 101.6%
Operating Margin %	0.33%	2.04%	3.11%	-22.5%	-1.41%	1.25%	0.98%	1.61%
Operating Income Growth %	-	645.34%	58.01%	-956.72%	91.21%	207.99%	-17.76%	101.6%
EBITDA	3.23M	17.49M	27.22M	-214.97M	-14.55M	27.18M	24.25M	44.14M
EBITDA Margin %	0.49%	2.22%	3.33%	-22.25%	-1.07%	1.64%	1.4%	2.08%
EBITDA Growth %	-	442.29%	55.66%	-889.67%	93.23%	286.81%	-10.79%	82.03%
D&A (Non-Cash Add-back)	1.07M	1.43M	1.84M	2.46M	4.57M	6.53M	7.27M	9.91M
EBIT	2.15M	16.06M	25.38M	-217.44M	-19.12M	20.65M	16.98M	34.23M
Net Interest Income	-6.42M	-6.91M	-1.92M	-1.07M	0	8.37M	10.89M	9.7M
Interest Income	0	0	0	0	0	8.37M	10.89M	9.7M
Interest Expense	6.42M	6.91M	1.92M	1.07M	0	0	0	0
Other Income/Expense	-6.42M	-6.91M	-1.92M	-1.07M	542K	8.37M	10.89M	9.7M
Pretax Income	-4.26M▲ 0%	9.15M▲ 314.6%	23.46M▲ 156.4%	-218.51M▼ 1031.3%	-18.58M▲ 91.5%	29.02M▲ 256.2%	27.87M▼ 4.0%	43.94M▲ 57.7%
Pretax Margin %	-0.65%	1.16%	2.87%	-22.61%	-1.37%	1.75%	1.61%	2.07%
Income Tax	-76K	1.21M	-7.44M	-27.86M	-6.52M	7.99M	10.83M	14.21M
Effective Tax Rate %	1.78%	13.19%	-31.71%	12.75%	35.07%	27.54%	38.84%	32.35%
Net Income	-3.04M▲ 0%	8.24M▲ 370.8%	31.24M▲ 279.0%	-188.23M▼ 702.5%	-8.59M▲ 95.4%	23.08M▲ 368.8%	14.38M▼ 37.7%	22.92M▲ 59.3%
Net Margin %	-0.46%	1.05%	3.82%	-19.48%	-0.63%	1.39%	0.83%	1.08%
Net Income Growth %	-	370.83%	278.99%	-702.45%	95.44%	368.83%	-37.67%	59.33%
Net Income (Continuing)	-4.19M	7.95M	30.9M	-190.65M	-12.06M	21.03M	17.04M	29.73M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	-2.46M	-2.76M	-3.1M	23.31M	19.95M	45.95M	48.26M	53.73M
EPS (Diluted)	-0.03▲ 0%	0.08▲ 363.5%	0.30▲ 284.6%	-1.77▼ 690.0%	-0.11▲ 93.8%	0.19▲ 272.7%	0.11▼ 42.1%	0.18▲ 63.6%
EPS Growth %	-	363.51%	284.62%	-690%	93.79%	272.73%	-42.11%	63.64%
EPS (Basic)	-0.03	0.08	0.30	-1.77	-0.11	0.20	0.12	0.19
Diluted Shares Outstanding	102.79M	105.71M	105.71M	107.84M	110.7M	124.69M	125.61M	128.89M
Basic Shares Outstanding	102.79M	105.71M	105.71M	107.84M	110.7M	116.73M	119.4M	122.18M
Dividend Payout Ratio	-	-	-	-	-	-	-	-

PRVA Balance Sheet

Privia Health Group, Inc. (PRVA) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	115.49M	129.6M	190.08M	446.68M	551.96M	700.8M	834.82M	911M
Cash & Short-Term Investments	39.11M	46.89M	84.63M	320.58M	347.99M	389.51M	491.15M	479.69M
Cash Only	39.11M	46.89M	84.63M	320.58M	347.99M	389.51M	491.15M	479.69M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	71.16M	77.34M	99.12M	117.4M	189.6M	290.77M	316.18M	400.9M
Days Sales Outstanding	39.5	35.9	44.28	44.35	51.01	64.02	66.46	68.93
Inventory	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-
Other Current Assets	0	0	0	0	14.37M	20.52M	27.5M	30.41M
Total Non-Current Assets	134M	140.61M	138.88M	239.7M	240.85M	299.1M	300.96M	458.38M
Property, Plant & Equipment	698K	5.62M	4.81M	14.14M	11.47M	8.94M	6.07M	9.3M
Fixed Asset Turnover	942.13x	139.87x	169.73x	68.35x	118.23x	185.49x	286.06x	228.31x
Goodwill	118.66M	118.66M	118.66M	127.94M	126.94M	138.75M	141.62M	209.84M
Intangible Assets	7.26M	6.62M	5.98M	59.74M	57.39M	107.63M	109.81M	215.92M
Long-Term Investments	0	0	0	0	0	0	0	0
Other Non-Current Assets	7.37M	9.7M	4.47M	4.52M	4.68M	8.58M	17.09M	21.04M
Total Assets	249.49M▲ 0%	270.2M▲ 8.3%	328.97M▲ 21.7%	686.37M▲ 108.6%	792.81M▲ 15.5%	999.9M▲ 26.1%	1.14B▲ 13.6%	1.37B▲ 20.6%
Asset Turnover	2.64x	2.91x	2.48x	1.41x	1.71x	1.66x	1.53x	1.55x
Asset Growth %	-	8.31%	21.75%	108.64%	15.51%	26.12%	13.59%	20.57%
Total Current Liabilities	101.32M	115.22M	146.94M	190.46M	264.27M	386.95M	449.15M	568.52M
Accounts Payable	4.67M	525K	5.24M	2.97M	6.73M	7.88M	9.76M	7.97M
Days Payables Outstanding	2.83	0.27	2.6	1.2	2.01	1.92	2.28	1.52
Short-Term Debt	7.13M	3.38M	875K	875K	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0
Other Current Liabilities	4.39M	86.86M	112.98M	148.2M	214.6M	332.05M	370.61M	503.07M
Current Ratio	1.14x	1.12x	1.29x	2.35x	2.09x	1.81x	1.86x	1.60x
Quick Ratio	1.14x	1.12x	1.29x	2.35x	2.09x	1.81x	1.86x	1.60x
Cash Conversion Cycle	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	62.12M	47.53M	38.38M	45.73M	9.49M	5.56M	3.19M	9.91M
Long-Term Debt	59.87M	39.73M	32.78M	31.69M	0	0	0	0
Capital Lease Obligations	0	0	0	11.04M	8.49M	5.25M	3.04M	7.33M
Deferred Tax Liabilities	0	2.88M	0	0	0	0	0	0
Other Non-Current Liabilities	2.25M	4.92M	5.59M	3M	1M	313K	153K	2.58M
Total Liabilities	163.44M	162.75M	185.32M	236.19M	273.76M	392.51M	452.34M	578.43M
Total Debt	67M	43.1M	33.66M	46.5M	11.5M	8.29M	5.59M	9.53M
Net Debt	27.89M	-3.79M	-50.97M	-274.08M	-336.49M	-381.22M	-485.56M	-470.15M
Debt / Equity	0.78x	0.40x	0.23x	0.10x	0.02x	0.01x	0.01x	0.01x
Debt / EBITDA	20.78x	2.46x	1.24x	-	-	0.30x	0.23x	0.22x
Net Debt / EBITDA	8.65x	-0.22x	-1.87x	-	-	-14.02x	-20.02x	-10.65x
Interest Coverage	0.34x	2.32x	13.24x	-203.21x	-	-	-	-
Total Equity	86.04M▲ 0%	107.46M▲ 24.9%	143.65M▲ 33.7%	450.18M▲ 213.4%	519.05M▲ 15.3%	607.39M▲ 17.0%	683.45M▲ 12.5%	790.94M▲ 15.7%
Equity Growth %	-	24.89%	33.68%	213.38%	15.3%	17.02%	12.52%	15.73%
Book Value per Share	0.84	1.02	1.36	4.17	4.69	4.87	5.44	6.14
Total Shareholders' Equity	88.5M	110.21M	146.75M	426.87M	499.09M	561.44M	635.18M	737.22M
Common Stock	959K	959K	960K	1.08M	1.15M	1.18M	1.2M	1.24M
Retained Earnings	-59.37M	-51.12M	-19.88M	-208.11M	-216.69M	-193.61M	-179.23M	-156.31M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0	0
Minority Interest	-2.46M	-2.76M	-3.1M	23.31M	19.95M	45.95M	48.26M	53.73M

PRVA Cash Flow Statement

Privia Health Group, Inc. (PRVA) cash flow — operating, investing & free cash flow history

Line item	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	5.25M	24.36M	38.89M	55.06M	47.2M	80.78M	109.28M	163.4M
Operating CF Margin %	0.8%	3.1%	4.76%	5.7%	3.48%	4.87%	6.29%	7.7%
Operating CF Growth %	-	364.05%	59.66%	41.57%	-14.28%	71.17%	35.28%	49.53%
Net Income	-4.19M	7.95M	30.9M	-190.65M	-12.06M	23.08M	14.38M	22.92M
Depreciation & Amortization	1.07M	1.43M	1.83M	2.46M	4.57M	6.53M	7.27M	9.91M
Stock-Based Compensation	1.94M	207K	484K	253.53M	67.36M	0	0	0
Deferred Taxes	-258K	716K	-7.83M	-28.41M	-7M	7.46M	8.82M	10.87M
Other Non-Cash Items	147K	332K	134K	157K	687K	35.05M	59.34M	75.42M
Working Capital Changes	6.54M	13.73M	13.37M	17.97M	-6.35M	8.66M	19.47M	44.29M
Change in Receivables	320K	-6.18M	-21.78M	-14.64M	-72.2M	-96.88M	-19.82M	-36.67M
Change in Inventory	0	0	0	0	0	0	0	0
Change in Payables	-983K	-4.14M	4.71M	0	6.85M	118.36M	52.85M	14.82M
Cash from Investing	-165K	-5.71M	-380K	-32.77M	-104K	-48.01M	-10.32M	-181.57M
Capital Expenditures	-220K	-5.71M	-380K	-547K	-104K	-113K	-5.02M	-1.2M
CapEx % of Revenue	0.03%	0.73%	0.05%	0.06%	0.01%	0.01%	0.29%	0.06%
Acquisitions	55K	0	0	-32.23M	125K	-47.89M	-5.3M	-181.72M
Investments	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	-125K	0	0	1.34M
Cash from Financing	15.36M	-10.87M	-767K	213.66M	-19.68M	8.74M	2.68M	6.7M
Debt Issued (Net)	15.25M	-10.87M	-875K	-875K	-33.25M	0	0	-2.46M
Equity Issued (Net)	0	0	0	223.69M	13.45M	8.74M	2.68M	8.05M
Dividends Paid	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0
Other Financing	106K	0	108K	-9.15M	125K	0	0	1.11M
Net Change in Cash	20.44M▲ 0%	7.78M▼ 61.9%	37.74M▲ 385.1%	235.94M▲ 525.1%	27.41M▼ 88.4%	41.52M▲ 51.4%	101.64M▲ 144.8%	-11.46M▼ 111.3%
Free Cash Flow	5.03M▲ 0%	18.65M▲ 270.8%	38.51M▲ 106.5%	54.51M▲ 41.5%	47.09M▼ 13.6%	80.67M▲ 71.3%	104.26M▲ 29.2%	162.2M▲ 55.6%
FCF Margin %	0.76%	2.37%	4.71%	5.64%	3.47%	4.87%	6%	7.64%
FCF Growth %	-	270.83%	106.5%	41.55%	-13.61%	71.31%	29.24%	55.57%
FCF per Share	0.05	0.18	0.36	0.51	0.43	0.65	0.83	1.26
FCF Conversion (FCF/Net Income)	-1.72x	2.95x	1.24x	-0.29x	-5.50x	3.50x	7.60x	7.13x
Interest Paid	3.72M	9.2M	1.93M	888K	713K	0	0	0
Taxes Paid	27K	316K	381K	504K	307K	0	0	0

PRVA Key Ratios

Privia Health Group, Inc. (PRVA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-3.54%	8.52%	24.88%	-63.39%	-1.77%	4.1%	2.23%	3.11%
Return on Invested Capital (ROIC)	1.42%	11.07%	19.39%	-121.35%	-8%	7.58%	6.01%	9.9%
Gross Margin	8.59%	8.71%	10.11%	6.59%	9.93%	9.74%	10.19%	9.87%
Net Margin	-0.46%	1.05%	3.82%	-19.48%	-0.63%	1.39%	0.83%	1.08%
Debt / Equity	0.78x	0.40x	0.23x	0.10x	0.02x	0.01x	0.01x	0.01x
Interest Coverage	0.34x	2.32x	13.24x	-203.21x	-	-	-	-
FCF Conversion	-1.72x	2.95x	1.24x	-0.29x	-5.50x	3.50x	7.60x	7.13x
Revenue Growth	-	19.58%	3.91%	18.25%	40.41%	22.19%	4.74%	22.26%

PRVA SEC Filings & Documents

Privia Health Group, Inc. (PRVA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Feb 26, 2026·SEC

Material company update

Dec 8, 2025·SEC

Material company update

Nov 6, 2025·SEC

10-K Annual Reports

FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 27, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

FY 2025

May 8, 2025·SEC

PRVA Frequently Asked Questions

Privia Health Group, Inc. (PRVA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Privia Health Group, Inc. (PRVA) reported $2.12B in revenue for fiscal year 2025. This represents a 223% increase from $657.6M in 2018.

Privia Health Group, Inc. (PRVA) grew revenue by 22.3% over the past year. This is strong growth.

Yes, Privia Health Group, Inc. (PRVA) is profitable, generating $22.9M in net income for fiscal year 2025 (1.1% net margin).

Dividend & Returns

Privia Health Group, Inc. (PRVA) has a return on equity (ROE) of 3.1%. This is below average, suggesting room for improvement.

Privia Health Group, Inc. (PRVA) generated $162.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More PRVA

Privia Health Group, Inc. (PRVA) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Privia Health Group, Inc.(PRVA)Earnings, Financials & Key Ratios

PRVA Key Insights

✓Strengths

✗Weaknesses

PRVA Price & Volume

PRVA Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

PRVA Recent Earnings

PRVA Peer Comparison

Compare PRVA vs Peers

vs AGIO

vs UNH

Compare Top 5

PRVA Income Statement

PRVA Balance Sheet

PRVA Cash Flow Statement

PRVA Key Ratios

PRVA SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

PRVA Frequently Asked Questions

Explore More PRVA

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation